Literature DB >> 30264380

Conflicts of interest disclosure forms and management in critical care clinical practice guidelines.

Waleed Alhazzani1,2, Kimberley Lewis3, Roman Jaeschke3,4, Bram Rochwerg3,4, Morten Hylander Møller5, Laura Evans6, Kevin C Wilson7, Sheena Patel8, Craig M Coopersmith9, Maurizio Cecconi10,11, Gordon Guyatt3,4, Elie A Akl4,12.   

Abstract

BACKGROUND: Trustworthy clinical practice guidelines (CPGs) require identification and careful management of conflicts of interest (COIs) among all participants in the guideline development. Furthermore, COIs are more common than anticipated. However, there are no universally accepted methods to identify and manage COIs.
OBJECTIVE: To describe and summarize the current COI disclosure forms and management policies in selected critical care professional societies that develop high-impact CPGs. In addition, we aim to provide suggestions to guideline developers on how to identify and manage different types of COIs.
METHODS: We searched PubMed and MEDLINE for CPGs published between 2013 and 2018 in English language and addressed general critical care topics. We then ranked the CPGs according to the numbers of citations and selected the first five critical care professional societies that sponsored the guidelines. We obtained the most recent COI declaration forms and management policies. Two reviewers abstracted data on different types of COI in each of the disclosure forms and management policies.
RESULTS: All selected professional critical care societies require that members declare direct financial COIs; four societies inquire specifically about intellectual COIs (involvement in primary research). Three out of five societies require members to disclose indirect institutional financial COIs; however, none inquire about other forms of institutional COI. We developed, by consensus, a streamlined framework to classify and manage different types of COIs.
CONCLUSION: The current COI disclosure forms of selected professional societies provide more attention to financial disclosures and COIs and less attention to detecting and managing intellectual COIs, while rarely addressing institutional COIs. We provide some suggestions for guideline developers on the classification and management of different COIs in the context of CPGs.

Entities:  

Keywords:  Clinical practice guidelines; Conflict of interest; Critical care

Mesh:

Year:  2018        PMID: 30264380     DOI: 10.1007/s00134-018-5367-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  23 in total

Review 1.  Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign.

Authors:  Jeanne Lenzer
Journal:  BMJ       Date:  2002-03-23

2.  Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography.

Authors:  Susan L Norris; Brittany U Burda; Haley K Holmer; Lauren A Ogden; Rongwei Fu; Lisa Bero; Holger Schünemann; Richard Deyo
Journal:  J Clin Epidemiol       Date:  2012-04-11       Impact factor: 6.437

3.  The vexing problem of guidelines and conflict of interest: a potential solution.

Authors:  Gordon Guyatt; Elie A Akl; Jack Hirsh; Clive Kearon; Mark Crowther; David Gutterman; Sandra Zelman Lewis; Ian Nathanson; Roman Jaeschke; Holger Schünemann
Journal:  Ann Intern Med       Date:  2010-05-17       Impact factor: 25.391

4.  An official American Thoracic Society Policy statement: managing conflict of interest in professional societies.

Authors:  Holger J Schünemann; Molly Osborne; Joel Moss; Constantine Manthous; Gregory Wagner; Leonard Sicilian; Jill Ohar; Shane McDermott; Lance Lucas; Roman Jaeschke
Journal:  Am J Respir Crit Care Med       Date:  2009-09-15       Impact factor: 21.405

5.  Accuracy of conflict-of-interest disclosures reported by physicians.

Authors:  Kanu Okike; Mininder S Kocher; Erin X Wei; Charles T Mehlman; Mohit Bhandari
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

6.  Authors of clinical trials reported individual and financial conflicts of interest more frequently than institutional and nonfinancial ones: a methodological survey.

Authors:  Maram B Hakoum; Nahla Jouni; Eliane A Abou-Jaoude; Divina Justina Hasbani; Elias A Abou-Jaoude; Luciane Cruz Lopes; Mariam Khaldieh; Mira Z Hammoud; Mounir Al-Gibbawi; Sirine Anouti; Gordon Guyatt; Elie A Akl
Journal:  J Clin Epidemiol       Date:  2017-04-12       Impact factor: 6.437

7.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Authors:  Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuk Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger
Journal:  Intensive Care Med       Date:  2017-01-18       Impact factor: 17.440

8.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

9.  Conflict of interest disclosures for clinical practice guidelines in the national guideline clearinghouse.

Authors:  Susan L Norris; Haley K Holmer; Lauren A Ogden; Shelley S Selph; Rongwei Fu
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

10.  Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study.

Authors:  Jennifer Neuman; Deborah Korenstein; Joseph S Ross; Salomeh Keyhani
Journal:  BMJ       Date:  2011-10-11
View more
  8 in total

1.  Intensive care medicine rapid practice guidelines (ICM-RPG): paving the road of the future.

Authors:  Waleed Alhazzani; Morten Hylander Møller; Emilie Belley-Cote; Giuseppe Citerio
Journal:  Intensive Care Med       Date:  2019-09-24       Impact factor: 17.440

2.  Conflicts of Interest and the Trustworthiness of Clinical Practice Guidelines.

Authors:  Anna Mathew; Catherine M Clase
Journal:  Clin J Am Soc Nephrol       Date:  2022-05-27       Impact factor: 10.614

3.  More than one third of clinical practice guidelines on low back pain overlap in AGREE II appraisals. Research wasted?

Authors:  Silvia Gianola; Silvia Bargeri; Michela Cinquini; Valerio Iannicelli; Roberto Meroni; Greta Castellini
Journal:  BMC Med Res Methodol       Date:  2022-07-05       Impact factor: 4.612

4.  Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations.

Authors:  Camilla Hansen Nejstgaard; Lisa Bero; Asbjørn Hróbjartsson; Anders W Jørgensen; Karsten Juhl Jørgensen; Mary Le; Andreas Lundh
Journal:  Cochrane Database Syst Rev       Date:  2020-12-08

5.  Reporting of conflicts of interest and of sponsorship of guidelines in anaesthesiology. A cross-sectional study.

Authors:  Damien Wyssa; Martin R Tramèr; Nadia Elia
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

6.  Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).

Authors:  Waleed Alhazzani; Morten Hylander Møller; Yaseen M Arabi; Mark Loeb; Michelle Ng Gong; Eddy Fan; Simon Oczkowski; Mitchell M Levy; Lennie Derde; Amy Dzierba; Bin Du; Michael Aboodi; Hannah Wunsch; Maurizio Cecconi; Younsuck Koh; Daniel S Chertow; Kathryn Maitland; Fayez Alshamsi; Emilie Belley-Cote; Massimiliano Greco; Matthew Laundy; Jill S Morgan; Jozef Kesecioglu; Allison McGeer; Leonard Mermel; Manoj J Mammen; Paul E Alexander; Amy Arrington; John E Centofanti; Giuseppe Citerio; Bandar Baw; Ziad A Memish; Naomi Hammond; Frederick G Hayden; Laura Evans; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2020-03-28       Impact factor: 17.440

7.  Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19).

Authors:  Waleed Alhazzani; Morten Hylander Møller; Yaseen M Arabi; Mark Loeb; Michelle Ng Gong; Eddy Fan; Simon Oczkowski; Mitchell M Levy; Lennie Derde; Amy Dzierba; Bin Du; Michael Aboodi; Hannah Wunsch; Maurizio Cecconi; Younsuck Koh; Daniel S Chertow; Kathryn Maitland; Fayez Alshamsi; Emilie Belley-Cote; Massimiliano Greco; Matthew Laundy; Jill S Morgan; Jozef Kesecioglu; Allison McGeer; Leonard Mermel; Manoj J Mammen; Paul E Alexander; Amy Arrington; John E Centofanti; Giuseppe Citerio; Bandar Baw; Ziad A Memish; Naomi Hammond; Frederick G Hayden; Laura Evans; Andrew Rhodes
Journal:  Crit Care Med       Date:  2020-06       Impact factor: 7.598

Review 8.  Neuromuscular blockade in patients with ARDS: a rapid practice guideline.

Authors:  Waleed Alhazzani; E Belley-Cote; M H Møller; D C Angus; L Papazian; Y M Arabi; G Citerio; B Connolly; L Denehy; A Fox-Robichaud; C L Hough; J H Laake; F R Machado; M Ostermann; T Piraino; S Sharif; W Szczeklik; P J Young; A Gouskos; K Kiedrowski; K E A Burns
Journal:  Intensive Care Med       Date:  2020-10-26       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.